GSS Investor Presentation - Proposed Merger with MAP
Filed with ASX · · 16 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Ltd. on 6ix
In the deck
Earlier from Genetic Signatures
- GSS and MAP agree to Commercial Terms for Merger
- Receipt of Section 249D Notice from BCAL Diagnostics
- Date of AGM and Closing Date for Director Nominations
- BDX Holdings of GSS Shares and receipt of Section 249D
- Final Director's Interest Notice
Later from Genetic Signatures
- Notice of Extraordinary General Meeting
- Becoming a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- 2026 Notice of Annual General Meeting
- GSS: Response to Media Speculation & BCAL letter to GSS
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures